Dr. Jimmy Lam, MD

Dr. Lam practices at South Pacific Surgery Center in Beverly Hills, California.

Dr. Lam's NPI, 1205326451, was assigned on May 14, 2018. Dr. Lam graduated from Boston University School Of Medicine in 2018. Dr. Lam holds California license A191252.

Dr. Lam's primary practice is South Pacific Surgery Center, at 99 La Cienega Boulevard Suite 102, Beverly Hills, CA 90211. The practice phone is (310) 360-7368.

Dr. Lam's primary practice is South Pacific Surgery Center in Beverly Hills, California. Dr. Lam is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Lam to 1 more group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lam practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Lam's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Lam is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Lam's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists benign or precancerous skin growths among the conditions Dr. Lam treats.

CMS data shows 626 Medicare services from Dr. Lam across 14 procedure codes in 2024, for 267 Medicare patients. Medicare paid $47,149 for them.

CMS counts 267 Medicare patients who saw Dr. Lam in 2024. The largest group is 65 to 74, with 123 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 33% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lam's median patient age at 52, with 53% women.

In 2024, Dr. Lam wrote 657 Medicare Part D claims for 200 patients. 92% of them were for generic drugs. CMS names the drug for 490 of them, across 12 drugs with 11 or more claims each, at $88,309 in total drug cost. In 2023, CMS named 474 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Lam for performance year 2024, reported as part of a group. Dr. Lam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 187 procedures of removal of skin lesions by Dr. Lam, more than 79% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Lam, published from 2011 to 2025. 2016 was the busiest year, with 2. The most frequent topics are Antibiotic Prophylaxis and Hong Kong. Dr. Lam's most frequent co-authors are Edward Joseph Caterson, MD, PhD, Rhoda M. Alani, MD and Samantha Rose Ellis, MD.

CMS Open Payments shows 126 general payments to Dr. Lam from 20 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $974.

Dr. Lam graduated from Boston University School Of Medicine in 2018.

Dr. Lam is in network with 12 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.